Sevoflurane for Treatment-Resistant Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study intends to carry out a prospective, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subanesthetic sevoflurane for treatment-resistant depression.
Epistemonikos ID: 6b89fd0d35ef82442bdc0c886297b3f7ad019178
First added on: May 09, 2024